Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-κB in AML carrying NPM1 mutations-Reference-Cited by-同舟云学术

Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-κB in AML carrying NPM1 mutations

Published:2008-04-10 Issue:6 Volume:22 Page:1234-1240
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Cilloni D,Messa F,Rosso V,Arruga F,Defilippi I,Carturan S,Catalano R,Pautasso M,Panuzzo C,Nicoli P,Messa E,Morotti A,Iacobucci I,Martinelli G,Bracco E,Saglio G

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu200868.pdf

Reference30 articles.

1. den Besten W, Kuo ML, Williams RT, Sherr CJ . Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein. Cell Cycle 2005; 4: 1593–1598.

2. Cheng K, Grisendi S, Clohessy JG, Majid S, Bernardi R, Sportoletti P et al. The leukemia-associated cytoplasmic nucleophosmin mutant is an oncogene with paradoxical functions: Arf inactivation and induction of cellular senescence. Oncogene 2007; 22: 7391–7400.

3. Colombo E, Martinelli P, Zamponi R, Shing DC, Bonetti P, Luzi L et al. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant. Cancer Res 15; 66: 3044–3050.

4. Colombo E, Bonetti P, Lazzerini Denchi E, Martinelli P, Zamponi R, Marine JC et al. Nucleophosmin is required for DNA integrity and p19Arf protein stability. Mol Cell Biol 2005; 25: 8874–8886.

5. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994; 263: 1281–1284.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromosomal Instability in Acute Myeloid Leukemia;Cancers;2021-05-28

2. The potential role of nucleophosmin (NPM1) in the development of cancer;Journal of Cellular Physiology;2021-05-07

3. Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia;Drug Resistance Updates;2020-09

4. Correlation of BCRP Expression to NPM1 Mutations in Acute Myeloid Leukemia;International Journal of Hematology and Oncology;2018-09-30

5. Effect of NPM1 type B mutation on the proliferation, invasion and chemosensitivity of THP-1 leukemia cells;PHARMAZIE;2017